Zynex Stock Based Compensation To Revenue from 2010 to 2024

ZYXI Stock  USD 8.34  0.08  0.97%   
Zynex's Stock Based Compensation To Revenue is increasing with slightly volatile movements from year to year. Stock Based Compensation To Revenue is predicted to flatten to 0.01. Stock Based Compensation To Revenue is a metric that compares the total value of stock-based compensation granted by Zynex Inc to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. View All Fundamentals
 
Stock Based Compensation To Revenue  
First Reported
2010-12-31
Previous Quarter
0.01245646
Current Value
0.00968
Quarterly Volatility
0.00720055
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Zynex financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zynex's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.4 M, Interest Expense of 1.1 M or Total Revenue of 193.5 M, as well as many indicators such as Price To Sales Ratio of 2.0, Dividend Yield of 0.0 or PTB Ratio of 7.97. Zynex financial statements analysis is a perfect complement when working with Zynex Valuation or Volatility modules.
  
Check out the analysis of Zynex Correlation against competitors.

Latest Zynex's Stock Based Compensation To Revenue Growth Pattern

Below is the plot of the Stock Based Compensation To Revenue of Zynex Inc over the last few years. It is a metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. Zynex's Stock Based Compensation To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zynex's overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation To Revenue10 Years Trend
Slightly volatile
   Stock Based Compensation To Revenue   
       Timeline  

Zynex Stock Based Compensation To Revenue Regression Statistics

Arithmetic Mean0.01
Geometric Mean0.01
Coefficient Of Variation60.20
Mean Deviation0
Median0.01
Standard Deviation0.01
Sample Variance0.000052
Range0.0306
R-Value0.40
Mean Square Error0.000047
R-Squared0.16
Significance0.13
Slope0.0007
Total Sum of Squares0.0007

Zynex Stock Based Compensation To Revenue History

2024 0.00968
2022 0.0148
2021 0.0125
2020 0.0335
2019 0.018
2018 0.0116
2017 0.002817

About Zynex Financial Statements

Investors use fundamental indicators, such as Zynex's Stock Based Compensation To Revenue, to determine how well the company is positioned to perform in the future. Although Zynex's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Stock Based Compensation To Revenue 0.01  0.01 

Currently Active Assets on Macroaxis

When determining whether Zynex Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zynex's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zynex Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zynex Inc Stock:
Check out the analysis of Zynex Correlation against competitors.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zynex. If investors know Zynex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zynex listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.30)
Earnings Share
0.14
Revenue Per Share
5.984
Quarterly Revenue Growth
0.001
Return On Assets
0.0399
The market value of Zynex Inc is measured differently than its book value, which is the value of Zynex that is recorded on the company's balance sheet. Investors also form their own opinion of Zynex's value that differs from its market value or its book value, called intrinsic value, which is Zynex's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zynex's market value can be influenced by many factors that don't directly affect Zynex's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zynex's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zynex is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zynex's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.